Management of postcardiac arrest myocardial dysfunction

Current Opinion in Critical Care

Volumn 19, Issue 3, 2013, Pages 195-201

  Bougouin, Wulfran ^a,b,c   Cariou, Alain ^a,b,c  

^a université Paris Cité   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Cardiac arrest; Cardiac failure; Shock

Indexed keywords

DOBUTAMINE;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR EQUIPMENT; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART ARREST; HEART MUSCLE ISCHEMIA; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; INDUCED HYPOTHERMIA; INOTROPISM; INTRAAORTIC BALLOON PUMP; MYOCARDIAL DISEASE; PATHOPHYSIOLOGY; POSTCARDIAC ARREST MYOCARDIAL DYSFUNCTION; PROGNOSIS; RESUSCITATION; REVIEW; RISK ASSESSMENT; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME;

CARDIOPULMONARY RESUSCITATION; DOBUTAMINE; HEART ARREST; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 84877755740     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283607740     Document Type: Review

References (56)

1. Sasson C, Rogers MAM, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010; 3:63-81.
2. Negovsky VA. Postresuscitation disease. Crit Care Med 1988; 16:942-946.
3. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002; 40:2110-2116.
4. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a 'sepsis-like' syndrome. Circulation 2002; 106:562-568.
5. Pene F, Hyvernat H, Mallet V, et al. Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest. Intensive Care Med 2005; 31:627-633.
6. Deantonio HJ, Kaul S, Lerman BB. Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol 1990; 13:982-985.
7. Ruiz-Bailén M, Aguayo de Hoyos E, Ruiz-Navarro S, et al. Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 2005; 66:175-181.
8. Xu T, Tang W, Ristagno G, et al. Postresuscitation myocardial diastolic dysfunction following prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med 2008; 36:188-192.
9. Chang W-T, Ma MH-M, Chien K-L, et al. Postresuscitation myocardial dysfunction: correlated factors and prognostic implications. Intensive Care Med 2007; 33:88-95.
10. Chalkias A, Xanthos T. Pathophysiology and pathogenesis of postresuscitation myocardial stunning. Heart Fail Rev 2011; 17:117-128.
11. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 1996; 28:232-240.
12. Fries M, Weil MH, Chang Y-T, et al. Microcirculation during cardiac arrest and resuscitation. Crit Care Med 2006; 34:S454-S457.
13. Kamohara T, Weil MH, Tang W, et al. A comparison of myocardial function after primary cardiac and primary asphyxial cardiac arrest. Am J Respir Crit Care Med 2001; 164:1221-1224.
14. Gazmuri RJ. Effects of repetitive electrical shocks on postresuscitation myocardial function. Crit Care Med 2000; 28:N228-N232.
15. Tang W, Weil MH, Sun S, et al. The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol 1999; 34:815-822.
16. Tang W, Weil MH, Sun S, et al. A comparison of biphasic and monophasic waveform defibrillation after prolonged ventricular fibrillation. Chest 2001; 120:948-954.
17. Ristagno G, Wang T, Tang W, et al. High-energy defibrillation impairs myocyte contractility and intracellular calcium dynamics. Crit Care Med 2008; 36:S422-S427.
18. Xie J, Weil MH, Sun S, et al. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997; 96:683-688.
19. Tang W, Weil MH, Sun S, et al. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92:3089-3093.
20. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
21. Gaieski DF, Band RA, Abella BS, et al. Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation 2009; 80:418-424.
22. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation 2012; 125:620-637.
23. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997; 336:1629-1633.
24. Dumas F, Cariou A, Manzo-Silberman S, et al. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest. Clinical perspective insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry. Circ Cardiovasc Interv 2010; 3:200-207.
25. Chelly J, Mongardon N, Dumas F, et al. Benefit of an early and systematic imaging procedure after cardiac arrest: insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry. Resuscitation 2012; 83:1444-1450.
26. Sideris G, Voicu S, Dillinger JG, et al. Value of postresuscitation electrocardiogram in the diagnosis of acute myocardial infarction in out-of-hospital cardiac arrest patients. Resuscitation 2011; 82:1148-1153.
27. Cronier P, Vignon P, Bouferrache K, et al. Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation. Crit Care 2011; 15:R122.
28. Anyfantakis ZA, Baron G, Aubry P, et al. Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. Am Heart J 2009; 157:312-318.
29. Gräsner JT, Meybohm P, Caliebe A, et al. Postresuscitation care with mild therapeutic hypothermia and coronary intervention after out-of-hospital cardiopulmonary resuscitation: a prospective registry analysis. Crit Care 2011; 15:R61.
30. Dumas F, Manzo-Silberman S, Fichet J, et al. Can early cardiac troponin I measurement help to predict recent coronary occlusion in out-of-hospital cardiac arrest survivors? Crit Care Med 2012; 40:1777-1784.
31. Voicu S, Sideris G, Deye N, et al. Role of cardiac troponin in the diagnosis of acute myocardial infarction in comatose patients resuscitated from out-ofhospital cardiac arrest. Resuscitation 2012; 83:452-458.
32. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501-2555.
33. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-556.
34. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563.
35. Delhaye C, Mahmoudi M, Waksman R. Hypothermia therapy: neurological and cardiac benefits. J Am Coll Cardiol 2012; 59:197-210.
36. Mottillo S, Sharma K, Eisenberg MJ. Therapeutic hypothermia in acute myocardial infarction: a systematic review. Can J Cardiol 2011; 27:555-561.
37. Ye S, Weng Y, Sun S, et al. Comparison of the durations of mild therapeutic hypothermia on outcome after cardiopulmonary resuscitation in the rat. Circulation 2012; 125:123-129.
38. Chenoune M, Lidouren F, Adam C, et al. Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits. Circulation 2011; 124:901-911; 1-7.
39. Hsu C-Y, Huang C-H, Chang W-T, et al. Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction. Shock 2009; 32:210-216.
40. Zobel C, Adler C, Kranz A, et al. Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 2012; 40:1715-1723.
41. Kern KB, Hilwig RW, Berg RA, et al. Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 1997; 95:2610-2613.
42. Vasquez A, Kern KB, Hilwig RW, et al. Optimal dosing of dobutamine for treating postresuscitation left ventricular dysfunction. Resuscitation 2004; 61:199-207.
43. Huang L, Weil MH, Tang W, et al. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med 2005; 33:487-491.
44. Kakavas S, Chalkias A, Xanthos T. Vasoactive support in the optimization of postcardiac arrest hemodynamic status: from pharmacology to clinical practice. Eur J Pharmacol 2011; 667:32-40.
45. Tennyson H, Kern KB, Hilwig RW, et al. Treatment of post resuscitation myocardial dysfunction: aortic counterpulsation versus dobutamine. Resuscitation 2002; 54:69-75.
46. Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296.
47. Manzo-Silberman S, Fichet J, Mathonnet A, et al. Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and IMPELLA Recover LP2.5. Resuscitation 2012.
48. Combes A, Leprince P, Luyt C-E, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36:1404-1411.
49. Cour M, Loufouat J, Paillard M, et al. Inhibition of mitochondrial permeability transition to prevent the postcardiac arrest syndrome: a preclinical study. Eur Heart J 2011; 32:226-235.
50. Niemann JT, Youngquist S, Rosborough JP, et al. Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model. Crit Care Med 2010; 38:1162-1167.
51. Sun S, Weil MH, Tang W, et al. Delta-opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 2004; 287:H969-H974.
52. Fang X, Tang W, Sun S, Weil MH. Delta-opioid-induced pharmacologic myocardial hibernation during cardiopulmonary resuscitation. Crit Care Med 2006; 34:S486-S489.
53. Cammarata G, Weil MH, Sun S, et al. Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival. Crit Care Med 2004; 32: S440-S443.
54. Huang C-H, Hsu C-Y, Tsai M-S, et al. Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows. Crit Care Med 2008; 36:S467-S473.
55. Najjar SS, Rao SV, Melloni C, et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA 2011; 305:1863-1872.
56. Niemann JT, Garner D, Khaleeli E, Lewis RJ. Milrinone facilitates resuscitation from cardiac arrest and attenuates postresuscitation myocardial dysfunction. Circulation 2003; 108:3031-3035.